Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain … – Xconomy
Xconomy |
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain …
Xconomy Gene therapy developer Tocagen is preparing an initial public stock offering to finance clinical trials of its experimental treatment for a form of brain c. Tocagen seeks $86M IPO to fund cancer gene therapy trial … Gene Therapy Developer Tocagen Files for $86M IPO | GEN Tocagen readies IPO | Seeking Alpha |
